EUVIMEDEUVIMED entdecken
BeobachtungsstudieFall-Kontroll-StudieOpen Access · CC BY 4.0

Interleukin-1β Gene (IL1B) rs1143634 (+3954 C>T) Polymorphism and Cutaneous Melanoma Risk: An Observational Case-Control Study in Northeast Italy

Sabina Cauci, Cinzia Buligan, Luca Bazzichetto, Gianluca Petris, Giuseppe Stinco iD

Genes · 2026

DOI: 10.3390/genes17070786 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Genes, 2026. Verfasst von Sabina Cauci und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (DAME), University of Udine, Piazzale Kolbe 4, 33100 Udine, Italy. Hauptthemen laut MEDLINE: Melanoma, Interleukin-1beta, Polymorphism, Single Nucleotide, Skin Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Udine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immune modulation is central to cutaneous melanoma, and antitumor immune responses may be influenced by host genetic background. This study investigated the association between the interleukin-1β gene (IL1B) exon 5 synonymous single-nucleotide polymorphism rs1143634 (+3954 C>T) and cutaneous melanoma in a Northeast Italian case–control cohort.

Methods

The study included 133 Caucasian patients with cutaneous melanoma and 945 healthy controls from Northeast Italy. The rs1143634 polymorphism was genotyped by PCR-restriction fragment length polymorphism (PCR-RFLP).

Results

Compared with healthy controls, melanoma patients showed higher frequencies of the rs1143634 T allele [27.8% vs. 20.3%; odds ratio (OR) = 1.52, 95% confidence interval (CI) = 1.13–2.03, p = 0.005] and CT genotype (43.6% vs. 31.6%; OR = 1.67, CI = 1.16–2.42, p = 0.006), whereas the CC genotype was less frequent (50.4% vs. 63.9%; OR = 0.57, CI = 0.40–0.83, p = 0.003). TT + CT genotypes were more frequent among non-metastatic melanoma cases than controls (OR = 2.23, CI = 1.37–3.64, p = 0.001), but the direct comparison between metastatic and non-metastatic cases was not statistically significant. Among melanoma patients, TT + CT carriers showed an inverse association with Stage IV disease (OR = 0.38, CI = 0.15–0.94, p = 0.036) and a positive association with upper-limb melanoma (OR = 9.10, CI = 1.11–75.0, p = 0.040); these subgroup findings were exploratory because of small numbers and wide confidence intervals.

Conclusions

These preliminary findings suggest a possible association between IL1B rs1143634 T allele carriage and cutaneous melanoma susceptibility in this cohort. The Stage IV and upper-limb observations should be considered hypothesis-generating. Larger independent studies, correction-aware statistical designs, cytokine or expression measurements, and functional validation are needed to confirm these observations and clarify their biological relevance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaInterleukin-1betaPolymorphism, Single NucleotideSkin NeoplasmsHumansFemaleMaleMiddle AgedCase-Control StudiesItalyGenetic Predisposition to DiseaseAgedAdultCutaneous Malignant MelanomaGenotypeGene FrequencyAlleles

Stichwörter der Autor:innen

IL-1 familyIL1BInterleukin-1betacase–control studycutaneous melanomainflammationinnate immunityrs1143634single-nucleotide polymorphismskin cancer

Substanzen

Interleukin-1betaIL1B protein, human

Autor:innen und Institutionen

  • Department of Medicine (DAME), University of Udine, Piazzale Kolbe 4, 33100 Udine, Italy.
  • Institute of Dermatology, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Santa Maria Della Misericordia, Friuli Centrale University Healthcare Hospital of Udine, 33100 Udine, Italy.
  • Fondazione Italiana Fegato ETS-Italian Liver Foundation ETS, 34149 Trieste, Italy.

ORCID-Profile: Giuseppe Stinco

Förderung

  • University of Udine

Zitieren

APA

Cauci, S., Buligan, C., Bazzichetto, L., Petris, G., & Stinco, G. (2026). Interleukin-1β Gene (IL1B) rs1143634 (+3954 C>T) Polymorphism and Cutaneous Melanoma Risk: An Observational Case-Control Study in Northeast Italy. Genes. https://doi.org/10.3390/genes17070786

Vancouver

Cauci S, Buligan C, Bazzichetto L, Petris G, Stinco G. Interleukin-1β Gene (IL1B) rs1143634 (+3954 C>T) Polymorphism and Cutaneous Melanoma Risk: An Observational Case-Control Study in Northeast Italy. Genes. 2026. doi:10.3390/genes17070786

BibTeX
@article{Cauci2026,
  author = {Cauci, Sabina and Buligan, Cinzia and Bazzichetto, Luca and Petris, Gianluca and Stinco, Giuseppe},
  title = {Interleukin-1β Gene (IL1B) rs1143634 (+3954 C>T) Polymorphism and Cutaneous Melanoma Risk: An Observational Case-Control Study in Northeast Italy},
  journal = {Genes},
  year = {2026},
  doi = {10.3390/genes17070786}
}
Kostenlos starten →